Dimensioni, segmenti e analisi del mercato dei farmaci per la psoriasi entro il 2025-2031
Psoriasis Therapeutics Market Report Analysis
Psoriasis Therapeutics Market
-
CAGR (2025 - 2031)8.4% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Astellas Pharma Inc.
- AstraZeneca plc,
- Boehringer Ingelheim GmbH
- F. Hofffmann-La Roche
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Valeant Pharmaceuticals International, Inc.
- Biocon Limited
- Eli Lilly and Company
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Classe di farmaci
- inibitori del TNF
- inibitori della PDE4
- bloccanti dell'interleuchina
- altri
By Tipo di molecola
- biologica
- piccole molecole
By Via di somministrazione
- orale
- parenterale
- topica
By Geografia
- Nord America
- Europa
- Asia-Pacifico
- Sud e Centro America
- Medio Oriente e Africa
Get Free Sample For